Science Daily -
4 Apr 2016 23:29
In the final, five-year follow-up report from the influential STAMPEDE trial, research shows that bariatric surgery's beneficial effects on blood glucose control in mild and moderately obese patients with type 2 diabetes may persist for up to five years, with the advantage over diabetes medications-only approach widening over time.
Share this Article